The overexpression of PARK7 protects prostate cancer cells from apoptosis via the inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TNFSF10) that acts as a specific inducer of apoptosis [43]. The gene discussed is PARK7; the disease is Familial prostate cancer.